20/20 Gene Systems Biotech SeedInvest/Crowdcube Campaign Now 1090%+ Overfunding
Machine learning, algorithms, early cancer detection, successful intervention? 20/20 GeneSystems, a digital diagnostics company with the core mission of reducing cancer mortality in the U.S. and around the world through early detection, sells what it believes to be the first multi-cancer blood test powered by real-world… Read More
Read more in: Global, Investment Platforms and Marketplaces, Offerings | Tagged 20/20 genesystems, ai, biotech, blood test, cancer, crowdcube, jonathan cohen, machine learning, onetest, reg a, seed invest